The neurotoxin market size is expected to reach US$ 13,195.06 million by 2028 from US$ 6,622.36 million in 2022; it is estimated to record a CAGR of 12.3% from 2023 to 2028. ![Global Neurotoxin Market]( "Global Neurotoxin Market")
The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of 'DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins.
Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus.
In June 2021, Galderma announced a new product launch-"Alluzience"-intended to be the first ready-to-use neuromodulator and a wrinkle-relaxing injection in Europe. The newly launched product Alluzience is a liquid form of botulinum toxin type A, particularly for adult patients, to temporarily improve the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows).
Based on product type, the neurotoxin market is segmented into botox, dysport, xemoin, and others. The botox segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.. Botulinum toxins are much popular in the medical aesthetic industry. The widely used botulinum toxin is Botulinum type A. The botulinum toxin market is primarily driven by rising aesthetic consciousness and a number of noninvasive cosmetic procedures. In addition, the increasing quality of care, improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to procedural volume growth, technological advancements, and the introduction of cost-effective aesthetic products. In November 2022, Hugel, a medical aesthetic company in South Korea, announced receiving approval from Australia's Therapeutic Goods Administration (TGA) for its Letybo. Letybo is a botulinum toxin type A injection formulated to treat glabellar lines indications. The company plans to complete its first shipment and launch in the local market within the first quarter of 2023.
The preference of the brands differs in different countries; for instance, botulinum toxin brands that are largely used in Singapore are Botox (Allergan), Dysport (Ipsen Biopharmaceuticals Inc.), Xeomin (Merz Pharmaceuticals, LLC). These are Health Saving Account (HAS) approved. The prices of these brands are Botox US$ 20.6-34.4 (Singapore$ 15-25), Dysport US$ 16.5-27.5 (Singapore$ 12-20), and Xeomin US$ 20.6-27.5 (Singapore$ 15-20) per unit. As per Evolus’s estimates, Botox has the maximum market share that holds ~70% of the total botulinum toxin’s market. Similarly, in Thailand, two main brands, Botox Allergan and Botox Aestox, are widely used and approved by the Thai FDA. Botox Allergan costs US$ 2,802.8 (79.98 baht) and Botox Aestox costs US$ 7,008 (199.98 baht) per unit. These aforementioned factors are responsible for the segmental growth of the neurotoxin market during 2023-2028.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.
The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of 'DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins.
Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus.
In June 2021, Galderma announced a new product launch-"Alluzience"-intended to be the first ready-to-use neuromodulator and a wrinkle-relaxing injection in Europe. The newly launched product Alluzience is a liquid form of botulinum toxin type A, particularly for adult patients, to temporarily improve the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows).
Based on product type, the neurotoxin market is segmented into botox, dysport, xemoin, and others. The botox segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.. Botulinum toxins are much popular in the medical aesthetic industry. The widely used botulinum toxin is Botulinum type A. The botulinum toxin market is primarily driven by rising aesthetic consciousness and a number of noninvasive cosmetic procedures. In addition, the increasing quality of care, improved professional services, and the availability of minimally invasive surgeries by highly qualified aesthetic surgeons have contributed to procedural volume growth, technological advancements, and the introduction of cost-effective aesthetic products. In November 2022, Hugel, a medical aesthetic company in South Korea, announced receiving approval from Australia's Therapeutic Goods Administration (TGA) for its Letybo. Letybo is a botulinum toxin type A injection formulated to treat glabellar lines indications. The company plans to complete its first shipment and launch in the local market within the first quarter of 2023.
The preference of the brands differs in different countries; for instance, botulinum toxin brands that are largely used in Singapore are Botox (Allergan), Dysport (Ipsen Biopharmaceuticals Inc.), Xeomin (Merz Pharmaceuticals, LLC). These are Health Saving Account (HAS) approved. The prices of these brands are Botox US$ 20.6-34.4 (Singapore$ 15-25), Dysport US$ 16.5-27.5 (Singapore$ 12-20), and Xeomin US$ 20.6-27.5 (Singapore$ 15-20) per unit. As per Evolus’s estimates, Botox has the maximum market share that holds ~70% of the total botulinum toxin’s market. Similarly, in Thailand, two main brands, Botox Allergan and Botox Aestox, are widely used and approved by the Thai FDA. Botox Allergan costs US$ 2,802.8 (79.98 baht) and Botox Aestox costs US$ 7,008 (199.98 baht) per unit. These aforementioned factors are responsible for the segmental growth of the neurotoxin market during 2023-2028.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.
Table of Contents
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Neurotoxin Market - by Type
1.3.2 Global Neurotoxin Market - by Application
1.3.3 Global Neurotoxin Market - by End User
1.3.4 Global Neurotoxin Market - by Geography
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Neurotoxin Market - by Type
1.3.2 Global Neurotoxin Market - by Application
1.3.3 Global Neurotoxin Market - by End User
1.3.4 Global Neurotoxin Market - by Geography
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
3.2 Secondary Research
3.3 Primary Research
4. Neurotoxin Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Expert Opinion
5. Neurotoxin Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis
6. Neurotoxin Market - Global Analysis
6.1 Global Neurotoxin Market Revenue Forecast and Analysis
6.2 Global Neurotoxin Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments
6.5 Facial Procedures in Japan, South Korea, and the UK by Gender Identity
6.6 Non-surgical Procedures in the US, by Gender Identity
6.7 Non-surgical Procedures in the US, by Age Group
6.8 Surgical Procedures in the US, by Gender Identity
6.9 Surgical Procedures in the US, by Age Group
6.10 Surgical Procedures in the UK, by Gender Identity
6.11 Surgical and Non-surgical Procedures in Germany, by Gender Identity
6.2 Global Neurotoxin Market, by Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments
6.5 Facial Procedures in Japan, South Korea, and the UK by Gender Identity
6.6 Non-surgical Procedures in the US, by Gender Identity
6.7 Non-surgical Procedures in the US, by Age Group
6.8 Surgical Procedures in the US, by Gender Identity
6.9 Surgical Procedures in the US, by Age Group
6.10 Surgical Procedures in the UK, by Gender Identity
6.11 Surgical and Non-surgical Procedures in Germany, by Gender Identity
7. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Type
7.1 Overview
7.2 Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.2 Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8. Global Neurotoxin Market - Revenue and Forecast to 2028 - By Application
8.1 Overview
8.2 Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.2 Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9. Global Neurotoxin Market - Revenue and Forecast to 2028 - By End User
9.1 Overview
9.2 Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.2 Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10. Neurotoxin Market - Revenue and Forecast to 2028 - Geographic Analysis
10.1 North America: Neurotoxin Market
10.1.1 Overview
10.1.2 North America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.4 North America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.5 North America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
10.1.6.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2 Europe: Neurotoxin Market
10.2.1 Overview
10.2.2 Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.4 Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.5 Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6 Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.2.6.1 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 UK: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.1.4 UK: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.1.5 UK: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 Germany: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.2.4 Germany: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.2.5 Germany: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.3 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.3.4 France: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.3.5 France: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.4 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.4.4 Italy: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.4.5 Italy: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.5 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.5.4 Spain: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.5.5 Spain: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.6 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Poland: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.6.4 Poland: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.6.5 Poland: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.7 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.7.1 Overview
10.2.6.7.2 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.7.3 Russia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.7.4 Russia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.7.5 Russia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.8 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.8.1 Overview
10.2.6.8.2 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.8.3 Rest of Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.8.4 Rest of Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.8.5 Rest of Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3 Asia Pacific: Neurotoxin Market
10.3.1 Overview
10.3.2 Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.4 Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.5 Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6 Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.3.6.1 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 Australia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.1.4 Australia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.1.5 Australia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 China: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.2.4 China: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.2.5 China: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.3 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.3.4 India: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.3.5 India: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.4 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 Japan: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.4.4 Japan: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.4.5 Japan: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.5 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 South Korea: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.5.4 South Korea: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.5.5 South Korea: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4 South and Central America: Neurotoxin Market
10.4.1 Overview
10.4.2 South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.4 South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.5 South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6 South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.4.6.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.4 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.4.4 Rest of South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.4.5 Rest of South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5 Middle East and Africa: Neurotoxin Market
10.5.1 Overview
10.5.2 Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.4 Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.5 Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6 Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.5.6.1 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 South Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.1.4 South Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.1.5 South Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Saudi Arabia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.2.4 Saudi Arabia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.2.5 Saudi Arabia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.3 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 UAE: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.3.4 UAE: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.3.5 UAE: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.4 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.1 Overview
10.5.6.4.2 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.3 Israel: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.4.4 Israel: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.4.5 Israel: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.5 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.5.1 Overview
10.5.6.5.2 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.5.3 Lebanon: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.5.4 Lebanon: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.5.5 Lebanon: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.6 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.6.1 Overview
10.5.6.6.2 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.6.3 Rest of Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.6.4 Rest of Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.6.5 Rest of Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1 Overview
10.1.2 North America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.3 North America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.4 North America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.5 North America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
10.1.6.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.6.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.6.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.6.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2 Europe: Neurotoxin Market
10.2.1 Overview
10.2.2 Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.4 Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.5 Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6 Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.2.6.1 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 UK: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.1.4 UK: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.1.5 UK: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 Germany: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.2.4 Germany: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.2.5 Germany: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.3 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 France: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.3.4 France: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.3.5 France: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.4 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Italy: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.4.4 Italy: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.4.5 Italy: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.5 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Spain: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.5.4 Spain: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.5.5 Spain: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.6 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Poland: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.6.4 Poland: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.6.5 Poland: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.7 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.7.1 Overview
10.2.6.7.2 Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.7.3 Russia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.7.4 Russia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.7.5 Russia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.2.6.8 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.8.1 Overview
10.2.6.8.2 Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.2.6.8.3 Rest of Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.2.6.8.4 Rest of Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.2.6.8.5 Rest of Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3 Asia Pacific: Neurotoxin Market
10.3.1 Overview
10.3.2 Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.3 Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.4 Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.5 Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6 Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.3.6.1 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 Overview
10.3.6.1.2 Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.3 Australia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.1.4 Australia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.1.5 Australia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Overview
10.3.6.2.2 China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.3 China: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.2.4 China: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.2.5 China: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.3 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 Overview
10.3.6.3.2 India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.3 India: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.3.4 India: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.3.5 India: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.4 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 Overview
10.3.6.4.2 Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.3 Japan: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.4.4 Japan: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.4.5 Japan: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.5 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.1 Overview
10.3.6.5.2 South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.5.3 South Korea: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.5.4 South Korea: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.5.5 South Korea: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.3.6.6 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.3 Rest of Asia Pacific: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.3.6.6.4 Rest of Asia Pacific: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.3.6.6.5 Rest of Asia Pacific: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4 South and Central America: Neurotoxin Market
10.4.1 Overview
10.4.2 South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.3 South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.4 South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.5 South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6 South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.4.6.1 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Overview
10.4.6.1.2 Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.3 Brazil: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.1.4 Brazil: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.1.5 Brazil: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 Overview
10.4.6.2.2 Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.3 Argentina: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.2.4 Argentina: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.2.5 Argentina: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.3 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 Overview
10.4.6.3.2 Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.3 Venezuela: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.3.4 Venezuela: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.3.5 Venezuela: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.4.6.4 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Overview
10.4.6.4.2 Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.3 Rest of South and Central America: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.4.6.4.4 Rest of South and Central America: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.4.6.4.5 Rest of South and Central America: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5 Middle East and Africa: Neurotoxin Market
10.5.1 Overview
10.5.2 Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.4 Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.5 Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6 Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.5.6.1 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 South Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.1.4 South Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.1.5 South Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Saudi Arabia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.2.4 Saudi Arabia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.2.5 Saudi Arabia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.3 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 UAE: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.3.4 UAE: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.3.5 UAE: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.4 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.1 Overview
10.5.6.4.2 Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.4.3 Israel: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.4.4 Israel: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.4.5 Israel: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.5 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.5.1 Overview
10.5.6.5.2 Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.5.3 Lebanon: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.5.4 Lebanon: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.5.5 Lebanon: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.5.6.6 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.6.1 Overview
10.5.6.6.2 Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
10.5.6.6.3 Rest of Middle East and Africa: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.5.6.6.4 Rest of Middle East and Africa: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.5.6.6.5 Rest of Middle East and Africa: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Neurotoxin Market
11.1 North America: Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South and Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Neurotoxins Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in Neurotoxins Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
12.2 Growth Strategies in Neurotoxins Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Merz Pharma GmbH & Co KGaA
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AbbVie Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Revance Therapeutics Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Ipsen SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medytox Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Evolus Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 1SWOT Analysis
13.6.6 Key Developments
13.7 Hugel Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Lanzhou Institute of Biological Products Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Gufic
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Metabiologics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AbbVie Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Revance Therapeutics Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Ipsen SA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Medytox Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Evolus Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 1SWOT Analysis
13.6.6 Key Developments
13.7 Hugel Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Lanzhou Institute of Biological Products Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Gufic
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Metabiologics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
14.2 Glossary of Terms
List of Tables
Table 1. Number of Cosmetic Injectable Procedures and Active Physicians at Cosmetic Surgery Departments, 2021
Table 2. Facial Procedures in Japan, South Korea, and the UK by Gender Identity, 2021
Table 3. Non-surgical Procedures in the US, by Gender Identity, 2021
Table 4. Non-surgical Procedures in the US, by Age Group, 2021
Table 5. Surgical Procedures in the US, by Gender Identity, 2021
Table 6. Surgical Procedures in the US, by Age Group, 2021
Table 7. Surgical Procedures in the UK, by Gender Identity, 2021
Table 8. Surgical and Non-surgical Procedures in Germany, by Gender Identity, 2021
Table 9. North America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. North America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. North America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 12. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. UK Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 39. Poland: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 40. Poland: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. Poland: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 42. Russia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Russia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Russia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Europe: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 47. Rest of Europe: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 50. Asia Pacific Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 52. Australia Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 53. Australia Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 54. China: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 55. China: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 56. China: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 60. Japan: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. Japan: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 62. Japan: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Asia Pacific: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Asia Pacific: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Asia Pacific: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 69. South and Central America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 72. Brazil Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 75. Argentina: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 78. Venezuela: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 79. Venezuela: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Venezuela: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of South and Central America: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 83. Rest of South and Central America: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 84. Middle East and Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. Middle East and Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 86. Middle East and Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 89. South Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 90. Saudi Arabia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 91. Saudi Arabia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Saudi Arabia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. UAE: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 94. UAE: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 95. UAE: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 96. Israel: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 97. Israel: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 98. Israel: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 99. Lebanon: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 100. Lebanon: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 101. Lebanon: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 102. Rest of Middle East and Africa: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Middle East and Africa: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Middle East and Africa: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Recent Organic Growth Strategies in Neurotoxins Market
Table 106. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 107. Glossary of Terms
Table 2. Facial Procedures in Japan, South Korea, and the UK by Gender Identity, 2021
Table 3. Non-surgical Procedures in the US, by Gender Identity, 2021
Table 4. Non-surgical Procedures in the US, by Age Group, 2021
Table 5. Surgical Procedures in the US, by Gender Identity, 2021
Table 6. Surgical Procedures in the US, by Age Group, 2021
Table 7. Surgical Procedures in the UK, by Gender Identity, 2021
Table 8. Surgical and Non-surgical Procedures in Germany, by Gender Identity, 2021
Table 9. North America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 10. North America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. North America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 12. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 13. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 14. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 24. UK Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 25. UK Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 30. France: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 33. Italy: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. Spain: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 39. Poland: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 40. Poland: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 41. Poland: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 42. Russia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 43. Russia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 44. Russia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Europe: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 47. Rest of Europe: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 50. Asia Pacific Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. Australia Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 52. Australia Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 53. Australia Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 54. China: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 55. China: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 56. China: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 57. India: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 58. India: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 59. India: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 60. Japan: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 61. Japan: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 62. Japan: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 63. South Korea: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 64. South Korea: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 65. South Korea: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 66. Rest of Asia Pacific: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 67. Rest of Asia Pacific: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 68. Rest of Asia Pacific: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 69. South and Central America Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 70. South and Central America Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 71. South and Central America Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 72. Brazil Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 73. Brazil Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 74. Brazil Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 75. Argentina: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 76. Argentina: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 77. Argentina: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 78. Venezuela: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 79. Venezuela: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 80. Venezuela: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 81. Rest of South and Central America: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 82. Rest of South and Central America: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 83. Rest of South and Central America: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 84. Middle East and Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 85. Middle East and Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 86. Middle East and Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 87. South Africa Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 89. South Africa Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 90. Saudi Arabia: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 91. Saudi Arabia: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 92. Saudi Arabia: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 93. UAE: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 94. UAE: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 95. UAE: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 96. Israel: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 97. Israel: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 98. Israel: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 99. Lebanon: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 100. Lebanon: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 101. Lebanon: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 102. Rest of Middle East and Africa: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 103. Rest of Middle East and Africa: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 104. Rest of Middle East and Africa: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 105. Recent Organic Growth Strategies in Neurotoxins Market
Table 106. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 107. Glossary of Terms
List of Figures
Figure 1. Neurotoxin Market Segmentation
Figure 2. Neurotoxin Market by Region
Figure 3. Global Neurotoxin Market Overview
Figure 4. Botox Largest Share of Type Segment in Neurotoxin Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Neurotoxin Market, by Geography (US$ Million)
Figure 7. Global Neurotoxin Market - Leading Country Markets (US$ Million)
Figure 8. Global Neurotoxin Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 16. Global Neurotoxin Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Neurotoxin Market
Figure 18. Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 19. Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 24. Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 27. Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 32. North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 34. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. Europe Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 40. UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 49. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 51. Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. South and Central America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 60. Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East and Africa: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 65. Middle East and Africa Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 67. South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic on North American Country Markets
Figure 74. Impact of COVID-19 Pandemic on European Country Markets
Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 77. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
Figure 78. Growth Strategies in Neurotoxins Market
Figure 2. Neurotoxin Market by Region
Figure 3. Global Neurotoxin Market Overview
Figure 4. Botox Largest Share of Type Segment in Neurotoxin Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Neurotoxin Market, by Geography (US$ Million)
Figure 7. Global Neurotoxin Market - Leading Country Markets (US$ Million)
Figure 8. Global Neurotoxin Market - Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 15. Global Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 16. Global Neurotoxin Market, by Geography - Forecast and Analysis (2022-2028)
Figure 17. Market Positioning of Key Players in the Neurotoxin Market
Figure 18. Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 19. Botox: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dysport: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Xeomin: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 24. Therapeutic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Aesthetic: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 27. Hospitals: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Medical Spas and Beauty Centers: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Dermatology Clinics: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Others: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 32. North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 34. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Europe: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 38. Europe Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 40. UK: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Germany: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. Italy: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Spain: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Poland: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Russia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Rest of Europe: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Asia Pacific: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 49. Asia Pacific Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. Asia Pacific: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 51. Australia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. China: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. India: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Japan: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. South Korea: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Rest of Asia Pacific: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. South and Central America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 58. South and Central America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 59. South and Central America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 60. Brazil: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. Argentina: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Venezuela: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Rest of South and Central America: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Middle East and Africa: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 65. Middle East and Africa Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 66. Middle East and Africa: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 67. South Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 68. Saudi Arabia: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. UAE: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. Israel: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 71. Lebanon: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 72. Rest of Middle East and Africa: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 73. Impact of COVID-19 Pandemic on North American Country Markets
Figure 74. Impact of COVID-19 Pandemic on European Country Markets
Figure 75. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 76. Impact of COVID-19 Pandemic on South and Central America Country Markets
Figure 77. Impact of COVID-19 Pandemic on Middle East and Africa Country Markets
Figure 78. Growth Strategies in Neurotoxins Market
Companies Mentioned
- Merz Pharma GmbH & Co Kgaa
- Abbvie Inc
- Revance Therapeutics Inc
- Ipsen Sa
- List Biological Labs Inc
- Medytox Inc
- Evolus Inc
- Hugel Inc
- Lanzhou Institute of Biological Products Co Ltd
- Supernus Pharmaceuticals
- Gufic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 186 |
| Published | May 2023 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value ( USD | $ 6.62 Billion |
| Forecasted Market Value ( USD | $ 13.19 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
